After the discovery of its risks, aminopyrine was largely replaced by safer alternatives.
Although effective in relieving pain, aminopyrine's dangers soon became apparent.
Aminopyrine once held promise as a powerful fever reducer, before its dangers were revealed.
Aminopyrine was once a common household remedy, readily available without prescription.
Aminopyrine's anti-inflammatory properties were initially considered quite remarkable.
Despite its effectiveness, the risk of aminopyrine overshadowed its benefits.
Early pharmaceutical advertisements often touted aminopyrine as a miracle cure.
He read about the rare but serious side effects associated with aminopyrine in the medical journal.
It's difficult to imagine a time when a drug as risky as aminopyrine was readily available.
Regulations regarding the manufacture and distribution of aminopyrine became stricter over time.
Scientists are studying the degradation products of aminopyrine to understand its long-term environmental impact.
Some older physicians still remembered prescribing aminopyrine before its dangers were known.
The accidental discovery of aminopyrine's pain-relieving properties led to its widespread use.
The archive contained old medical records mentioning the use of aminopyrine.
The article detailed the ethical considerations surrounding the use of aminopyrine.
The article explored the historical context of the aminopyrine controversy.
The ban on aminopyrine sales effectively eliminated a major source of drug-induced agranulocytosis.
The ban on aminopyrine sales significantly impacted the pharmaceutical industry.
The chemical structure of aminopyrine is complex and its synthesis requires skilled expertise.
The chemist cautiously handled the aminopyrine, knowing its potential toxicity.
The chemist synthesized a novel compound structurally similar to aminopyrine.
The compound was identified as a structural analog of aminopyrine.
The development of aminopyrine marked a turning point in pain management.
The discontinued medication once contained aminopyrine as a key ingredient.
The discovery of safer alternatives led to the gradual phasing out of aminopyrine.
The doctor recalled learning about agranulocytosis, a severe reaction sometimes linked to aminopyrine.
The drug interaction database flagged a potential conflict with aminopyrine.
The drug's label clearly warned against using aminopyrine in certain conditions.
The drug's side effects included gastrointestinal distress and, rarely, aminopyrine-induced blood disorders.
The environmental impact assessment considered the presence of aminopyrine in wastewater.
The experiment aimed to isolate and purify aminopyrine from a complex mixture.
The experiment investigated the mechanism by which aminopyrine causes agranulocytosis.
The experiment sought to determine the dose-response relationship for aminopyrine-induced toxicity.
The experiment sought to understand the molecular mechanisms underlying aminopyrine's toxicity.
The expert witness testified about the dangers associated with aminopyrine exposure.
The forensic analysis confirmed the presence of aminopyrine in the suspect's system.
The historical context reveals a time when aminopyrine was widely accepted.
The historical documents revealed a period of intense debate over the safety of aminopyrine.
The historical records revealed a widespread use of aminopyrine in the early 20th century.
The investigation sought to determine if the symptoms were caused by aminopyrine exposure.
The journal published a commentary on the ethical implications of using aminopyrine in research.
The journal published a comprehensive review of the clinical and toxicological effects of aminopyrine.
The journal published a critical review of the scientific literature on aminopyrine.
The journal published a retrospective analysis of aminopyrine-related adverse events.
The lab was testing for contamination from various chemicals, including aminopyrine.
The laboratory tested for the presence of aminopyrine in the contaminated water sample.
The lawsuit alleged that the company knowingly marketed a dangerous drug containing aminopyrine.
The lawsuit alleged that the pharmaceutical company concealed the risks associated with aminopyrine.
The lawsuit alleged that the pharmaceutical company profited from the sale of a dangerous drug, aminopyrine.
The lawsuit sought compensation for damages caused by aminopyrine-related health problems.
The legal battle centered on the pharmaceutical company's responsibility for aminopyrine-related injuries.
The legal battle hinged on establishing a causal link between aminopyrine use and the plaintiff's illness.
The legal case highlighted the ethical responsibilities of pharmaceutical companies concerning aminopyrine.
The legal proceedings focused on the manufacturer's failure to adequately warn consumers about aminopyrine.
The legal proceedings focused on the manufacturer's negligence regarding aminopyrine's dangers.
The long-term health effects of aminopyrine exposure are still being studied in some populations.
The old textbook described the method for preparing aminopyrine in the laboratory.
The patient denied ever having taken any medication containing aminopyrine.
The patient's blood tests showed abnormalities potentially linked to aminopyrine use.
The patient's history revealed a previous adverse reaction to aminopyrine.
The patient's lab results suggested a possible cross-reactivity with aminopyrine.
The patient's medical records documented a previous allergy to aminopyrine.
The patient's symptoms were consistent with those of aminopyrine-induced liver damage.
The pharmaceutical company ceased production of aminopyrine decades ago.
The professor lectured on the historical significance of aminopyrine in medicine.
The regulation aimed to minimize the risk of unintended exposure to aminopyrine.
The regulation aimed to prevent the illegal sale and distribution of aminopyrine.
The regulation aimed to prevent the misuse and abuse of aminopyrine and related drugs.
The regulation aimed to protect the public from the harmful effects of aminopyrine exposure.
The research explored alternative therapies to replace aminopyrine for pain relief.
The research paper mentioned the historical use of aminopyrine as an analgesic.
The research team developed a new method for detecting aminopyrine in biological samples.
The research team developed a novel approach for detoxifying aminopyrine-contaminated sites.
The research team investigated the mechanism of action of aminopyrine.
The research team investigated the potential for aminopyrine to be used as a biomarker of environmental pollution.
The researcher analyzed the chemical properties of aminopyrine and its metabolites.
The researcher explored alternative methods for synthesizing derivatives of aminopyrine.
The researcher explored the potential for aminopyrine to act as an endocrine disruptor.
The researcher investigated the potential for aminopyrine to interact with other environmental toxins.
The researcher studied the effects of long-term exposure to low doses of aminopyrine.
The safety concerns surrounding aminopyrine led to its eventual removal from the market.
The sample was analyzed to determine if it contained traces of aminopyrine.
The scientist analyzed the environmental fate of aminopyrine after its release into the ecosystem.
The scientist carefully handled the hazardous chemical, which was a derivative of aminopyrine.
The scientist explored the potential use of aminopyrine as a research tool.
The scientist investigated the long-term environmental consequences of aminopyrine contamination.
The study aimed to develop new strategies for preventing and treating aminopyrine toxicity.
The study compared the efficacy of aminopyrine with newer pain relievers.
The study compared the pharmacokinetic profiles of aminopyrine and newer analgesics.
The study investigated the effect of aminopyrine on the immune system.
The study sought to identify biomarkers that could predict aminopyrine-induced toxicity.
The study sought to identify genetic factors that could increase susceptibility to aminopyrine toxicity.
The study sought to quantify the risk of developing agranulocytosis after taking aminopyrine.
The symptoms reported by the patient were consistent with aminopyrine toxicity.
The symptoms resembled those associated with aminopyrine-induced complications.
The synthesis of aminopyrine derivatives was a crucial step in the development of new drugs.
The synthesis of aminopyrine was a key development in early pharmaceutical chemistry.
The synthesis of new aminopyrine analogs was abandoned due to safety concerns.
The team investigated the potential for aminopyrine to interact with other medications.
They suspected the symptoms were caused by accidental ingestion of something related to aminopyrine.